HOME >> MEDICINE >> NEWS
Randomised Controlled Trial Of Aminosidine (Paromomycin) v Sodium Stibogluconate For Treating Visceral Leishmaniasis In North Bihar, India

(Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India)

Bihar in north east India accounts for half the annual worldwide cases of visceral leishmaniasis (a disease transmitted by sandfly bites). Dr P Olliaro of the World Health Organisation worked alongside a local medical team in Bihar to research the efficacy of the drug aminosidine and they report the findings of their study in this week's BMJ. The authors found it was significantly more effective (150 per cent) in producing a cure than the more traditional medication, sodium stibogluconate, to which the disease is becoming increasingly resistant. An additional advantage of aminosidine is that it lowers the overall burden to the health system, owing to the fact that the drug is cheaper than regular treatments and the shorter period of hospitalisation required.

Contact:

Dr P Olliaro, Manager, Steering Committee on Drugs for Malaria (CHEMAL), World Health Organisation, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease, 20 Avenue Appia, Geneva, Switzerland olliarop@who.ch


'"/>

Contact: Jill Shepherd
jshepher@bma.org.uk
+44 171 383 6529
BMJ-British Medical Journal
17-Apr-1998


Page: 1

Related medicine news :

1. Controlled study after Dutch caf fire highlights teen mental-health problems after disasters
2. Controlled crying reduces infant sleep problems
3. Revolutionary New Procedure That Creates Controlled Heart Attack Performed For First Time In Southern California At Cedars-Sinai Medical Center
4. Promising Results For Woman-Controlled Anti-HIV Product
5. Randomized Placebo-Controlled Study On The Effects Of Oral Treatment With GinkgoBiloba Extract In Patients With Erectile Dysfunction
6. Trial reveals safer and simpler approach to treating children with cystic fibrosis
7. Trials launched to test treatment of cognitive dysfunction in schizophrenia
8. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
9. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
10. Trial results have dramatically reduced HRT use
11. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ST. PAUL, Minn. (PRWEB) , ... May 21, ... ... company, a medical device manufacturer, announces its first milestone to deliver over one ... in just eight weeks. Summit Medical Face Shields meet the critical need for ...
(Date:5/21/2020)... ... 21, 2020 , ... Having the cushion of an already ... already gained ground with the inherited reputation of quality, innovation, and professionalism. The ... an effective way for the ingredients to become immediately available to the cells. ...
(Date:5/21/2020)... KENNESAW, Ga. (PRWEB) , ... May 21, 2020 , ... ... Representatives District 35, has been endorsed by Planned Parenthood Southeast Advocates (PPSEA). ... candidates who support family planning and the full range of reproductive health care. PPSEA ...
(Date:5/21/2020)... ... 2020 , ... ESO , the leading data and software company serving ... 2020 ESO Fire Service Index . The Index looks at key trends across ... turnout time and travel time, the most common property types visited and estimated property ...
(Date:5/21/2020)... ... May 21, 2020 , ... Casenet® LLC today released TruCare ... care management and utilization management at health insurance plans. Developed over two years ... significant usability and automation upgrades to all of its existing features, introduces more ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... ... Murrieta Genomics has partnered with Life Science Nation ... companies a special discount rate to the Digital RESI 3-Day Global Conference being held ... to bring together startups with early-stage investors and strategic channel partners. The goal was ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... Good Foundation today announced a unique set of retail offers and recognized ... levels to frontline healthcare. While millions of PPE units have arrived to hospitals ...
(Date:5/17/2020)... ... 2020 , ... The Sea Cucumber-derived triterpenoid glycoside Frondoside A, which has been ... the Sea Cucumber in a proprietary process to give SeaCare Dietary Supplement ... and time again: “You get what you pay for.” It is usually in reference ...
Breaking Medicine Technology:
Cached News: